Current Products
   Products in the Pipeline
S.No. Name Designation

Brief profile


Dr.K. Narayana Reddy

Managing Director

Dr. Narayana Reddy has a vast Research experience in Biomedical sciences at molecular level over 35 years and valuable executive experience of over 20 years in Pharma and Biotech industries. He holds a Ph.D and worked in reputed research institutions in India and abroad like National Institute of Nutrition, Hyderabad and Institute for Physical Biochemistry, Munich, Germany and has guided many doctoral students. He has several research publications of international repute and a commendable US Patent to his credit. He is instrumental in designing and establishing Biochemistry and Drug Screening laboratories at Dr. reddy's Research Foundation (DRF) of Dr. Reddy's Labs. He had a versatile experience as Chief of Biochemistry and Scientific Affairs at DRF. He has built motivated drug discovery teams at DRF, where two antidiabetic insulin sensitizer drugs were discovered and subsequently licenced to Novo Nordisk, Denmark for clinical development. As Chief Operating Officer of the emerging Biotech company, DS Genomic Solutions, Hyderabad, he has designed and set up an advanced technical facility for providing genomic services as a CRO.


Dr. P.K Mythili

Principal Scientist

Dr. Mythili holds a Ph.D and has more than 15 years of research experince in the area of Genetics, Gene cloning and Expression. She has published over 15 research papers in reputed journals. She has worked for 5 years at Osmania University and ICRISAT, Hyderabad as Geneticist. She Contributed to the colning and expression of majority of the antigen clones, chymosin, human serum albumin, erythropoietin and interferon beta 1a and 1b that are available at SBL. She has developed a simple method for acivating chymosin, enzymes required in cheese production, which resulted in a process patent awarded to SBL. She is curently on lein at Universirty of Tennessee, Memphis, TN, USA, working in the laboratory of Dr. Guntaka on cloning and characterization of E1 and E2 of HCV, two potential candidates for HCV vaccine. She is also characterizing G-CSF, Hirudin, and Insulin Clones.

Home  |  Careers  |  News & Events  |  Site Map  |  Reach Us